Tribune.ma

Tribune. Le vote du meilleur but, le podcast L'Vestiaire, les interviews football et encore plus.

What’s new on Tribune.ma: Check updates and related news right now. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Tribune.ma popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Tribune

Subscribe to related news

Corbus Pharmaceuticals Holdings, Inc. (CRBP: OTCQB) | Corbus Pharmaceuticals Reports 2014 Financial Results and Provides...
via pennystockhub

NORWOOD, MA–(Marketwired – Feb 10, 2015) – Corbus Pharmaceuticals Holdings, Inc. (OTCQB: CRBP) (the “Company”), an emerging drug development company focused on the development and commercialization of its lead product candidate, Resunab™, for the treatment...
Corbus Pharmaceuticals Reports 2014 Financial Results and Provides 2015 Business Update
via saudiindustrydaily

NORWOOD, MA—(Marketwired – Feb 10, 2015) – Corbus Pharmaceuticals Holdings, Inc. ( OTCQB : CRBP ) (the “Company”), an emerging drug development company focused on the development and commercialization of its lead product candidate, Resunab™, for the...
Corbus Pharmaceuticals Observes Annual Rare Disease Day
via sauditopbusiness

NORWOOD, MA—(Marketwired – Feb 27, 2015) – Corbus Pharmaceuticals Holdings, Inc. ( OTCQB : CRBP ) (the “Company”), an emerging drug development company focused on the development and commercialization of its lead product candidate, Resunab™, for the...
Corbus Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference on February 9, 2016
via kuwaitfinancialexpress

NORWOOD, MA—(Marketwired – Feb 1, 2016) – Corbus Pharmaceuticals Holdings, Inc. ( NASDAQ : CRBP ) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases, announced...
Corbus Pharmaceuticals Reports 2015 Second Quarter Financial Results and Provides Business Update
via egyptmarketgateway

NORWOOD, MA—(Marketwired – Aug 13, 2015) – Corbus Pharmaceuticals Holdings, Inc. ( NASDAQ : CRBP ) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases, announced...